A pilot study to evaluate the safety and efficacy of ustekinumab in patients with takayasu arteritis.
Phase of Trial: Phase IV
Latest Information Update: 29 Jul 2015
At a glance
- Drugs Ustekinumab (Primary)
- Indications Takayasu syndrome
- Focus Adverse reactions; Therapeutic Use
- 29 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.